Leptomeningeal metastasis: survival and prognostic factors in 155 patients
- PMID: 15337619
- DOI: 10.1016/j.jns.2004.05.008
Leptomeningeal metastasis: survival and prognostic factors in 155 patients
Abstract
In this single-center retrospective study, 155 consecutive patients with leptomeningeal metastasis (LM) were analyzed for the prognostic role of patient- and therapy-related variables. Ten percent of the patients received radiotherapy alone, 32% had chemotherapy alone, 31% received radiochemotherapy, 17% had supportive therapy only, and 10% were not evaluable for therapy. Chemotherapy was systemic (17%), combined systemic and intrathecal (10%), or intrathecal only (35%). Clinical improvement was noted in 41% of the patients. Overall median survival time (MST) was 4.8 months. Survival varied considerably depending on the type of primary tumor in this largest published cohort of LM patients. Univariate Cox regression analysis revealed that age >60 and elevated cerebrospinal fluid (CSF) albumin or lactate levels were therapy-independent predictors of poor survival in the entire cohort as well as in the subgroup of patients with systemic primary tumors (n=105). The assessment of three therapy-independent parameters allows to group LM patients into groups of low, intermediate, and high risk of poor survival. Moreover, the application of systemic chemotherapy was a positive prognostic factor in patients with subarachnoid lesions detected by neuroimaging (RR 1.94, p=0.001) or with extra-CNS tumor deposits (RR 1.52, p=0.05). The results of this study suggest that systemic chemotherapy alone or in combination with other therapeutic modalities may improve outcome in patients with subarachnoid tumor cell deposits detectable by neuroimaging.
Similar articles
-
Brain metastases in breast cancer: prognostic factors and management.Breast Cancer Res Treat. 2008 Oct;111(3):523-30. doi: 10.1007/s10549-007-9806-2. Epub 2007 Nov 8. Breast Cancer Res Treat. 2008. PMID: 17990100
-
Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy.Cancer. 1998 May 1;82(9):1756-63. Cancer. 1998. PMID: 9576299 Clinical Trial.
-
[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].Ai Zheng. 2006 Dec;25(12):1543-9. Ai Zheng. 2006. PMID: 17166383 Chinese.
-
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review.
-
[Primary central nervous system lymphoma--a report of 32 cases with literature review].Ai Zheng. 2006 Apr;25(4):476-80. Ai Zheng. 2006. PMID: 16613684 Review. Chinese.
Cited by
-
Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.PLoS One. 2019 Jan 10;14(1):e0210074. doi: 10.1371/journal.pone.0210074. eCollection 2019. PLoS One. 2019. PMID: 30629621 Free PMC article.
-
Neuraxis Metastases Of Primary Central Nervous System Tumors: A Review Of Clinicopathological And Radiographic Characters Of 198 Cases In A Single Center.Cancer Manag Res. 2019 Nov 20;11:9829-9841. doi: 10.2147/CMAR.S217672. eCollection 2019. Cancer Manag Res. 2019. PMID: 31819620 Free PMC article.
-
Targeted Treatment of Brain Metastases.Curr Neurol Neurosci Rep. 2017 Apr;17(4):37. doi: 10.1007/s11910-017-0741-2. Curr Neurol Neurosci Rep. 2017. PMID: 28326470 Review.
-
Ocular symptoms secondary to meningeal carcinomatosis in a patient with lung adenocarcinoma: a case report.BMC Ophthalmol. 2012 Dec 18;12:65. doi: 10.1186/1471-2415-12-65. BMC Ophthalmol. 2012. PMID: 23249254 Free PMC article.
-
Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting.BMC Cancer. 2020 Jun 1;20(1):501. doi: 10.1186/s12885-020-06984-1. BMC Cancer. 2020. PMID: 32487151 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical